Introduction {#s0005}
============

The response of cells to either an acute (single high dose) or chronic (repeated low/moderate doses) exposure to oxidising agents is quite different. Depending on the degree of the oxidising insult, acute exposure could trigger a series of intracellular antioxidant defence mechanisms that counteract the damage caused but if these are not sufficient, cells will die by apoptosis or necrosis, again depending on the extent of the oxidative insult [@bib1; @bib2]. In chronically exposed cells, it is anticipated that the antioxidant defence mechanism will be altered as repeated exposure of cells to oxidants usually provokes the development of a series of adaptive responses that are distinct from those following acute exposure. Because of such adaptive responses, cells may withstand high toxic doses of the oxidising agent that would otherwise be lethal. Excess production of reactive oxygen species (ROS) has been implicated in progression of cardiovascular, neurodegenerative, and chronic inflammatory diseases as well as cancer and aging [@bib2; @bib3; @bib4; @bib5; @bib6; @bib7]. The study of the mechanisms underlying the adaptive responses of cells to oxidising agents should provide clues to understanding the promotion and progression of such disorders.

The involvement of hydrogen peroxide (H~2~O~2~) in numerous types of cell and tissue injury is well-documented [@bib8; @bib9; @bib10; @bib11; @bib12]. Although H~2~O~2~ itself has low reactivity toward cell constituents, it is capable of forming potent ROS in the presence of trace amounts of catalytic labile iron via Fenton chemistry. The potentially toxic labile iron exists in cells as a transit pool of catalytically active iron complexes which is distinct from intracellular iron associated with proteins and is known as the labile iron pool (LIP). Iron belonging to this pool is considered to be in steady-state equilibrium, loosely bound to low-molecular-weight compounds, accessible to permeant chelators, and metabolically and catalytically reactive [@bib13]. Under physiological conditions, cells protect themselves either by the H~2~O~2~-degrading enzymes catalase and glutathione peroxidase (GPx) [@bib14] or by minimising the intracellular level of potentially harmful redox-active LIP via the cytosolic iron regulatory proteins 1 and 2 (i.e., IRP-1 and IRP-2) which function as posttranscriptional regulators of both iron uptake via transferrin receptor (TfR) and iron sequestration by the iron-storage protein, ferritin (Ft) [@bib15; @bib16]. However under pathological conditions including acute oxidative stress, these conventional cellular defences are often insufficient, because the system is overwhelmed either by an increase in H~2~O~2~ formation [@bib10; @bib17; @bib18] and/or by an excess presence of labile iron [@bib16; @bib19]. The increase in intracellular LIP in oxidative stress conditions such as short exposure to H~2~O~2~ and the damaging effect of iron-catalysed oxidative damage has been shown in numerous cellular and animal studies [@bib19; @bib20; @bib21; @bib22; @bib23; @bib24; @bib25; @bib26; @bib27].

Under physiological conditions, most of the iron that is not metabolised is stored in Ft. Ft is an ubiquitously expressed cytosolic iron-storage protein that forms a hetero-oligomeric protein shell composed of two different subunits, ferritin heavy chain (FtH) with ferroxidase activity and ferritin light chain (FtL) that promotes iron nucleation [@bib28; @bib29]. Ft plays a dual role in LIP homeostasis, acting on the one hand as an iron-sequestering protein and on the other hand as a potential source of labile iron [@bib8; @bib30]. The characterisation of cellular models in which Ft expression is modulated has shown that the ferroxidase catalytic site of the FtH has a central role in regulating iron availability. In turn, this has secondary effects on a number of cellular activities, which include proliferation and resistance to oxidative damage [@bib28; @bib29]. Iron is also liberated from Ft as a consequence of normal turnover in lysosomal compartments, where it is thought to be recycled for synthesis of new iron-containing proteins [@bib31; @bib32]. This source of LIP has been shown to be active in the cell-damaging processes caused by oxidative stress in the form of H~2~O~2~ or ultraviolet A (UVA, 320--400 nm) radiation, promoting lysosomal rupture and release of potent hydrolytic enzymes to the cytosol [@bib20; @bib33; @bib34] which in turn leads to both proteolytic degradation of cytosolic proteins notably Ft and secondary secondary harm to various cellular constituents notably mitochondrial injury leading to apoptotic or necrotic cell death (depending on the extent of insult) [@bib21; @bib35].

The existence of a storage protein inside mitochondria, called mitochondrial ferritin (FtMt), has been shown to protect the mitochondria of cells from iron-dependent oxidative damage [@bib29; @bib36]. It has been suggested that the primary function of FtMt is the control of ROS formation through the regulation of mitochondrial iron availability, which results in a cytoprotective effect [@bib29]. In HeLa cells, FtMt overexpression has been shown to protect the cells against H~2~O~2~-induced cytochrome *c* release from mitochondria and reduction of the activity of the mitochondrial Fe/S enzymes [@bib37]. The cytoprotective function of FtMt has also been linked to its iron-sequestering activity capable of reducing the size of cytosolic and mitochondrial LIP, both of which catalyse oxidative damage under oxidative stress conditions [@bib8; @bib37; @bib38; @bib39; @bib40].

In this study, we used a cell model composed of two human Jurkat T cell lines (parental, J16; H~2~O~2~-resistant, HJ16) to assess the mechanisms underlying the increased cellular resistance that occurs after chronic adaptation to oxidative stress. The possible role of LIP, Ft, and FtMt in increasing the resistance of cells to H~2~O~2~ was also investigated.

Materials and methods {#s0010}
=====================

Materials {#s0015}
---------

Cell culture materials were obtained from Gibco (Germany) except for fetal bovine serum (FBS) (PAA Laboratories, Austria) and RPMI-1640 medium (Promocell, Germany). All chemicals were from Sigma-Aldrich Chemical (Poole, UK) except protease inhibitor cocktail tablets, Annexin-V-FLUOS, bovine serum albumin (BSA) that was supplied from Roche (Mannheim, Germany), glutathione reductase (GR), H~2~O~2~ solution, and Mowiol 4-88 from Calbiochem (CN Biosciences LTD, Nottingham), dimethyl sulfoxide (DMSO) from VWR International Ltd (Leicestershire, England), DPBS (Dulbecco's phosphate-buffered saline with Ca^2+^ and Mg^2+^) from Cambrex (Belgium), cathepsin B antibody from Santa Cruz Biotechnology, Inc. (Santa Cruz, California), calcein-acetoxymethyl ester (CA-AM) and LysoSensor Green DND-153 from Molecular Probes (Leiden, Netherlands), and an ApoGlow assay kit from Lumitech (UK). Salicylaldehyde isonicotinoyl hydrazone (SIH) was a kind gift from Dr James Dowden (Department of Pharmacy and Pharmacology, Bath University, Bath, UK).

Cell culture {#s0020}
------------

The Jurkat J16 cells are a human T-cell leukemia cell line. The polyclonal H~2~O~2~-resistant cell line "HJ16" was derived from the J16 cell line after gradual adaptation to 3 mM H~2~O~2~. For this purpose, the J16 cell culture was diluted in serum-free RPMI at a density of 1×10^6^ cells/ml. Cells were then treated with H~2~O~2~ at a concentration determined by their tolerance (generally a concentration of H~2~O~2~ causing over 60% cell death), and incubated at 37 °C for 2 h. After this time, cells were harvested by centrifugation (350 *g*, 5 min) and resuspended in an equal volume of 10% FBS RPMI. After 18 h incubation, cell numbers and survival were determined using trypan blue exclusion on a hematocytometer. This protocol was repeated every 2--3 weeks, depending on recovered cell numbers, with increasing concentrations of H~2~O~2~ over a period of 6 months. An H~2~O~2~-tolerant cell line (up to a dose of 3 mM) was designated HJ16. Stocks of HJ16 cells were stored in liquid nitrogen and defrosted when needed. Both cell lines were cultured routinely in RPMI-1640 medium supplemented with 10% v/v heat inactivated FBS, 2.7% w/v sodium bicarbonate, 2 mM [L]{.smallcaps}-glutamine, and 50 IU/ml of penicillin and streptomycin.

We also attempted to isolate highly resistant clones for comparison. However our attempts failed to identify clones that had higher resistance to a H~2~O~2~ concentration of 3 mM than the polyclonal HJ16 cell line (data not shown). For this reason and the time-consuming nature of the clonal expansion, in the present study, we concentrated our efforts to perform an in-depth characterization of the polyclonal HJ16 cell line.

Treatments {#s0025}
----------

H~2~O~2~ treatments (0.05--3 mM) were performed in serum-free media (SFM) for 30 min at 37 °C. Following the treatment, cells were resuspended and incubated in the conditioned media (CM) for 4 or 24 h at 37 °C prior to experimentation. Buthionine-\[*S,R*\]sulfoximine (BSO) treatments (2--250 µM) were carried out in CM for 18 h at 37 °C prior to experimentation. Desferrioxamine mesylate (DFO) treatment (100 µM) was carried in CM for 18 h at 37 °C prior to experimentation.

Flow cytometry {#s0030}
--------------

The percentages of apoptotic and necrotic cells from a minimum of 10,000 cells (events) were scored after dual staining of cells with propidium iodide (PI) and Annexin-V-FLUOS staining by flow cytometry using the FACS vantage (Becton Dickinson) as described previously [@bib21].

ATP measurement {#s0035}
---------------

The ATP concentrations in cells were determined luminometrically using an ApoGlow assay kit (Lumitech, UK) as described previously [@bib21]. Briefly prior to experiments, cells were resuspended in serum- and glucose-free EMEM media containing 2 mM pyruvate (PNG medium) to allow oxidative phosphorylation. After adaptation to this medium (45 min), cells were resuspended in serum-free RPMI and exposed to various H~2~O~2~ doses and ATP concentrations in cells were determined in a Streptech (UK) luminometer at 4 or 24 h following H~2~O~2~ treatments.

Lysosensor immunofluorescence and cathepsin B immunocytochemistry {#s0040}
-----------------------------------------------------------------

For Lysosensor immunofluorescence, cells were treated with LysoSensor Green DND-153 (1 µM) for 2 h at 37 °C as described previously [@bib20]. Cathepsin B immunocytochemistry was performed using cathepsin B antibody (dilution 1:100) and the secondary FITC-conjugated goat anti-rabbit IgG antibody (Sigma, F9887; dilution 1:100 ) as described previously [@bib41]. After either Lysosensor treatment or cathepsin B immunocytometry, cells were analysed by confocal laser scanning microscope LSM 510 with a Plan-Apochromat 63 x /1.40 oil DIC objective (Carl Zeiss, Germany) (excitation at 488 nm; emission at 505 nm).

Neutral red uptake assay {#s0045}
------------------------

For neutral red (NR) assay, cells were first washed with PBS and then incubated for 1.5 h at 37 °C with 2 ml of the NR dye (0.4% W/V) in 10% FBS-RPMI medium. Following centrifugation, cells were fixed with the fixing solution (40% v/v formaldehyde + 10% w/v CaCl~2~) for 1 min and then lysed with lysis buffer (1% v/v acetic acid + 50% v/v ethanol). The absorbance was measured at 540 nm by VERSAmax plate reader (Molecular devices, California).

LIP determination by fluorescence calcein assay (CA assay) {#s0050}
----------------------------------------------------------

The determination of the absolute level of cytosolic "LIP," that is operationally defined as the sum of the cytosolic level of CA-bound iron (i.e., \[CA-Fe\]) and free iron (i.e., \[Fe\] unbound to CA), the cell-dependent dissociation constant (*K*~d~) for CA-Fe was determined as described previously [@bib13; @bib21].

Ft/FtMt ELISA {#s0055}
-------------

The cytosolic Ft and FtMt were determined by means of elisa (enzyme-linked immunosorbent assay) as described by Santambrogio et al. [@bib36; @bib42]. The antibodies used were monoclonal-specific FtH (i.e., rH02), FtL (i.e., LF03), or mouse polyclonal FtMt-specific MoαHuFtMt and their HRP-labeled equivalents (LF03-HRP 1:3000, rH02-HRP 1:15000, MoαHuFtMt-HRP 1:6000). The peroxidase activity was developed with *o*-phenylenediamine dihydrochloride. Protein measurements were determined by the Bradford assay [@bib43]. The results were expressed as nanogram Ft (FtH or FtL) or FtMt per milligram protein.

Glutathione measurement {#s0060}
-----------------------

Total intracellular glutathione after various treatments was measured according to the spectrophotometric method developed by Tietze [@bib44] as described previously [@bib14]. This method is an enzymatic recycling procedure which offers a high sensitivity rate. Glutathione is assayed by a system in which it is readily oxidised by DTNB \[5,5\'-dithiobis(2-nitrobenzoic acid)\] and reduced by NADPH (i.e., reduced form of nicotinamide adenine dinucleotide phosphate) in the presence of GR. The rate of 2-nitro-5-thiobenzoic acid formation is monitored and the level of intracellular glutathione equivalents in cells is determined by the comparison of the result with a standard curve with the known amounts of glutathione. The total intracellular glutathione was normalised by total cellular protein using the Bradford assay.

Catalase activity measurement {#s0065}
-----------------------------

Catalase activity in both normal and H~2~O~2~-resistant cells was quantified by the direct measurement of H~2~O~2~ consumption as described by Moysan et al. [@bib45] and Pourzand et al. [@bib14]. Catalase activity was normalised to sample protein content by the Bradford assay and expressed as Unit per milligram (U/mg) protein. One unit (U) is defined as 1 µmol H~2~O~2~ consumed per minute.

GPx activity measurement {#s0070}
------------------------

The GPx activity in both normal and H~2~O~2~-resistant cells was measured according to the method developed by Flohe and Günzler [@bib46], with a few modifications. Briefly, 1×10^6^ cells were lysed in 500 µl of lysis buffer (100 mM Tris-HCl, 300 mM KCl, 0.1% v/v peroxide-free Triton X-100, pH 7.6) by sonication. The cells were then pelleted by centrifugation and the clear supernatant was collected. A test mix containing 100 mM Tris-HCl (pH 7.6), 5 mM EDTA, 3 mM reduced glutathione (GSH), 0.2 mM NADPH, 0.1% v/v Triton X-100, and 600 mU/ml GR was prepared and preincubated at 37 °C for 10 min. The reaction was started by the addition of 10 µl *tert*-butyl hydroperoxide (TBHP, 50 µM final concentration) and the NADPH consumption rate was spectrophotometrically measured at 340 nm for 5 min. GPx activity was normalised to sample protein content by the Bradford assay (expressed as U/mg protein). One unit was defined as 1 µmol NADPH oxidised per minute.

Statistical analysis {#s0075}
--------------------

Results were expressed as the mean ± standard deviation (SD). Significant differences (*P* \< 0.05) were determined by either paired or unpaired *t* test after one-way analysis of variance.

Results {#s0080}
=======

*Determination of the level of H*~*2*~*O*~*2*~*resistance* {#s0085}
----------------------------------------------------------

To evaluate the levels of resistance of J16 and HJ16 cells to H~2~O~2~, the levels of apoptotic and necrotic cell death were scored by flow cytometry using the dual Annexin-V/PI staining method. For this purpose, cells were first treated with H~2~O~2~ up to a final concentration of 3 mM and then incubated for 4 or 24 h at 37 °C prior to analysis by flow cytometry. An example of such analysis is illustrated in [Fig. 1](#f0005){ref-type="fig"}A. In this example J16 and HJ16 cell lines were either untreated or treated with H~2~O~2~ concentrations of 0.5 and 3 mM. As displayed in [Fig. 1](#f0005){ref-type="fig"}A, the parental J16 cells were much more sensitive to H~2~O~2~ treatment than the H~2~O~2~-adapted HJ16 cells. Indeed while a moderate H~2~O~2~ dose of 0.5 mM decreased dramatically the percentage of live cells (i.e., lower left quadrant, LL) in J16 cells, the same treatment only marginally affected the percentage of live cells in HJ16 cells when compared to their respective untreated controls. Similarly at a high concentration of 3 mM H~2~O~2~, while over 70% live HJ16 cells were still present in the LL quadrant, in J16 cells almost no live J16 cells were detectable (i.e., 0.37% live cells).

We also performed further comparative flow cytometry analyses of both cell lines at 4 (data not shown) or 24 h (see [Fig. 1](#f0005){ref-type="fig"}B) following treatment with H~2~O~2~ concentrations of 0, 0.1, 0.5, 1, and 3 mM. These results revealed that both cell lines were fairly resistant to H~2~O~2~-mediated apoptotic cell death and that necrosis was the primary mode of cell death in these cell lines. A comparison of the percentage of necrotic cell death in both cell lines following H~2~O~2~ treatment in [Fig. 1](#f0005){ref-type="fig"}B confirmed the initial observations made in [Fig. 1](#f0005){ref-type="fig"}A, since the HJ16 cell line was significantly more resistant than the J16 cell line to H~2~O~2~ doses higher than 0.5 mM.

Intracellular ATP depletion as a hallmark of necrotic cell death. {#s0090}
-----------------------------------------------------------------

Progression of death stimuli to necrosis and apoptosis depends on the mitochondrial-mediated damage and on ATP levels [@bib20; @bib47; @bib48; @bib49]. To assess the correlation between the percentage of H~2~O~2~-mediated necrosis in cells (as measured by flow cytometry) and the extent of intracellular ATP depletion, an Apoglow kit was used to monitor the modulation of the intracellular levels of ATP, 4 and 24 h following treatment of both cell lines with H~2~O~2~. The results ([Fig. 2](#f0010){ref-type="fig"}) revealed that although H~2~O~2~ promotes ATP depletion in both parental J16 and H~2~O~2~-resistant HJ16 cells in a dose-dependent manner, in HJ16 cells the decrease in ATP occurs to a lesser extent than the J16 cells. As the presence of ATP is essential for the activation of apoptosis protease activating factor-1 (Apaf-1) and subsequent activation of caspases that induce apoptosis [@bib1], it appears that the H~2~O~2~-induced depletion of ATP in these cells provides a rational explanation for the predominance of necrotic cell death induced by H~2~O~2~ as illustrated in [Fig. 1](#f0005){ref-type="fig"}. Furthermore as ATP depletion is a consequence of oxidative damage to mitochondrial membranes [@bib2; @bib21], the results of [Fig. 2](#f0010){ref-type="fig"} further demonstrate that compared to J16 cells, the HJ16 cells are more resistant to H~2~O~2~-induced mitochondrial membrane damage.

*Evaluation of H*~*2*~*O*~*2*~*-mediated lysosomal membrane damage* {#s0095}
-------------------------------------------------------------------

Three independent assays (NR uptake, Lysosensor DND-153, and cathepsin B immunocytochemistry) were used to assess the level of lysosomal membrane damage in cells 24 h following H~2~O~2~ treatments. [Fig. 3](#f0015){ref-type="fig"}A shows the distribution of the fluorescent dye within the intact lysosomes of living J16 and HJ16 cells. As can be seen, following H~2~O~2~ treatment, the intensity of fluorescent dye in the lysosomal compartments decreased in a dose-dependent manner in J16 cells, reflecting the leakage of lysosomal membranes and consequently the release of fluorescent dye into the cytosol. At a high H~2~O~2~ dose of 1 mM, almost no fluorescent vesicles were observed in the J16 cells. In contrast, the lysosomes in HJ16 cells were quite resistant to H~2~O~2~-mediated membrane damage (see [Fig. 3](#f0015){ref-type="fig"}A). The treatment of J16 cells with H~2~O~2~ also provoked a dose-dependent delocalisation of cathepsin B from the lysosomal compartments to cytosol (see [Fig. 3](#f0015){ref-type="fig"}B). At high concentrations of 0.5 and 1 mM H~2~O~2~, only very few localised bright dots were detectable in J16 cells. In contrast in HJ16 cells, the cathepsin B delocalisation remained very marginal, indicating that HJ16 lysosomes are highly resistant to H~2~O~2~-induced oxidative damage. The quantification of lysosomal membrane damage with the NR uptake assay further confirmed the results obtained with Lysososensor and cathepsin B assays. As shown in [Fig. 3](#f0015){ref-type="fig"}C, the level of retention of the acidotrophic NR dye was decreased in a dose-dependent manner in H~2~O~2~-treated J16 cells, reflecting the loss of lysosomal membrane integrity. At H~2~O~2~ concentrations of 0.5 mM and higher, J16 cells lost over 90% of the lysosomal dye. In contrast, in H~2~O~2~-treated HJ16 cells, the dye leakage from acidic organelles was low even when cells were treated with high concentrations of 1 and 3 mM H~2~O~2~.

*Evaluation of the relationship between oxidant-induced increase in cytosolic LIP and resistance of cells to H*~*2*~*O*~*2*~ {#s0100}
----------------------------------------------------------------------------------------------------------------------------

### Evaluation of cytosolic LIP level {#s0105}

The evaluation of cytosolic LIP in both cell types following various treatments was performed with the CA-fluorescence assay. In order to compare the absolute levels of cytosolic LIP in these cell lines, the dissociation constants (*K*~d~) of CA-bound iron (CA-Fe) were first determined in CA-loaded cells of both types using the CA-fluorescent assay. We then determined the cell volume of each cell line so that the LIP concentrations could be further calibrated. The results were then expressed as cytosolic "LIP" which is operationally defined as the sum of concentrations of free CA-unbound iron \[Fe\] and CA-bound iron \[CA-Fe\] (see Materials and methods and [@bib15]). The *K*~d~ value of J16 cells (28.82±5.06 µM) was 1.4-fold higher than that of the HJ16 cells (20.06±2.51 µM). In contrast, the cell volume of HJ16 cells (1.6±0.19) was 2-fold higher than that of parental cells (0.85±0.06).

[Table 1](#t0005){ref-type="table"} summarises the absolute cytosolic LIP levels of both cell lines in the absence or presence of DFO and/or H~2~O~2~ treatment. The basal level concentrations of LIP were similar in both cell lines, indicating that the adaptation of J16 cells to high concentrations of H~2~O~2~ does not alter the basal cytosolic LIP level in HJ16 cells. H~2~O~2~ treatment with a concentration of 0.5 mM provoked an increase in the level of cytosolic LIP in both cell lines, although the absolute measurable level of cytosolic LIP in H~2~O~2~-treated HJ16 cells was found to be significantly lower than in H~2~O~2~-treated J16 cells. Furthermore a comparison of the basal and H~2~O~2~-induced cytosolic LIP levels in both cell lines revealed that the fold-increase in LIP levels in H~2~O~2~-treated J16 cells was much higher than that in the HJ16 cells (i.e., 3-fold in J16 and 1.7-fold in HJ16 cells) when compared to their corresponding untreated control cells. The latter result suggested that the higher increase in cytosolic LIP following H~2~O~2~ treatment of J16 cells may contribute to the higher susceptibility of J16 cells to H~2~O~2~-induced oxidative damage, since labile iron is a strong catalyst of biological oxidation. The LIP measurements were also performed in cells pretreated with the iron chelator DFO. The pretreatment with DFO was carried out for 18 h since it has been shown that DFO can only enter the cells via the slow process of endocytosis that takes several hours. It is then transported into the lysosomal compartment where it remains intact (i.e., undegraded) and acts as a sink for iron, decreasing rapidly the size of lysosomal and cytosolic LIP [@bib32; @bib50; @bib51; @bib52]. The results of [Table 1](#t0005){ref-type="table"} also revealed that the DFO treatment was not only able to deplete the basal level concentrations of LIP in both cell lines but also to suppress the H~2~O~2~-inducible increase in LIP. The suppression of basal and H~2~O~2~-induced LIP was also further confirmed in both cell lines pretreated with the highly lipophilic strong iron chelator SIH for 18 h prior to H~2~O~2~ treatment (data not shown).

Using the CA assay, the cytosolic LIP levels were also measured immediately after H~2~O~2~ treatment of both parental and H~2~O~2~-resistant cells with additional H~2~O~2~ concentrations (i.e., 0.05, 0.1, 0.5, 1, and 3 mM). The results ([Fig. 4](#f0020){ref-type="fig"}) revealed that following H~2~O~2~ treatment with a range of concentrations of H~2~O~2~ (i.e., 0.05--1 mM), the levels of cytosolic LIP were increased in both cell lines. However a comparison of H~2~O~2~-mediated LIP increase in both parental and H~2~O~2~-resistant cell lines revealed that the extent of LIP release in parental J16 cells was up to 3.5-fold higher than that in the H~2~O~2~-resistant HJ16 cells. The latter difference in LIP increase was more significant for the first three concentrations of H~2~O~2~ (i.e., 0.05, 0.1, and 0.5 mM) used. Interestingly, when J16 cells were exposed to H~2~O~2~ concentrations of 1 and 3 mM, the cytosolic LIP levels began to decrease substantially. ([Fig. 4](#f0020){ref-type="fig"}). In contrast only a small decrease in cytosolic LIP was detectable in HJ16 cells treated with a high concentration of 3 mM H~2~O~2~.

The decrease in cytosolic LIP values in J16 cells that were treated with high concentrations of 1 and 3 mM H~2~O~2~ is almost certainly due to higher toxicity of the concentrations applied and leakage of the dye from the damaged cells. Indeed during the LIP measurement, there was no detectable CA leakage in the supernatant of J16 cells treated with H~2~O~2~ concentrations of 0.05--0.5 mM. However at higher H~2~O~2~ concentrations of 1 and 3 mM, substantial CA leakage was detected in the J16 cells (i.e., up to 40% of the total CA fluorescence measured in CA-loaded control cells). However in HJ16 cells the CA leakage was only detectable in the supernatant of cells treated with H~2~O~2~ concentrations of 1 and 3 mM (i.e., up to 8% of the total CA fluorescence measured in CA-loaded control cells).

### *Effect of DFO on lysosomal membrane damage induced by H*~*2*~*O*~*2*~ {#s0110}

Three independent assays (NR uptake, Lysosensor DND-153, and cathepsin B immunocytochemistry) were used to assess the level of lysosomal membrane damage in cells 24 h following H~2~O~2~ treatments of cells pretreated with DFO. As illustrated in [Fig. 3](#f0015){ref-type="fig"}A--E, overnight treatment of cells with DFO significantly protected the J16 cells against H~2~O~2~-induced lysosomal damage. However in HJ16 cells that were already fairly resistant to H~2~O~2~-induced lysosomal damage, DFO pretreatment did not provide any additional protective effect.

### *Effect of DFO on mitochondrial membrane damage induced by H*~*2*~*O*~*2*~ {#s0115}

The levels of resistance of cells to H~2~O~2~-induced ATP depletion were also monitored with an Apoglow kit 4 and 24 h after H~2~O~2~ treatment of cells pretreated with DFO. As displayed in [Fig. 2](#f0010){ref-type="fig"}C--F, DFO treatment significantly protected both the J16 and the HJ16 cells against H~2~O~2~-induced ATP depletion at both 4 and 24 h time points after H~2~O~2~ treatment. Similarly, overnight treatment of cells with SIH (100 µM) also significantly protected both cell lines against H~2~O~2~-induced ATP depletion (data not shown). As ATP depletion is the direct consequence of oxidative damage to mitochondrial membranes and is a hallmark of necrotic cell death, our results strongly suggest that H~2~O~2~-mediated mitochondrial damage and necrotic cell death are iron dependent.

### *Effect of DFO on necrotic cell death induced by H*~*2*~*O*~*2*~ {#s0120}

The levels of resistance of cells to H~2~O~2~-induced necrotic cell death were also monitored by flow cytometry 24 h after H~2~O~2~ treatment of cells pretreated with DFO. As displayed in [Fig. 5](#f0025){ref-type="fig"}, overnight DFO treatment fully protected both J16 and HJ16 cells against H~2~O~2~-induced necrotic cell death. Overnight treatment of cells with SIH (100 µM) also significantly protected both cell lines against H~2~O~2~-induced necrotic cell death (data not shown).

Taken together the results described in the sections above strongly suggest a direct correlation between the level of H~2~O~2~-induced increase in cytosolic LIP and the extent of H~2~O~2~-induced lysosomal and mitochondrial damage and necrotic cell death in both cell types.

Role of Ft in differential sensitivity of cells to oxidative stress {#s0125}
-------------------------------------------------------------------

The role of Ft in differential sensitivity of our cell models to H~2~O~2~ was assessed by measuring the levels of FtH and FtL subunits in the presence or absence of H~2~O~2~ and/or DFO. Since in Western blot analysis, Ft subunit levels of both cell types were not detectable, we performed our measurements with the highly sensitive ELISA method. [Fig. 6](#f0030){ref-type="fig"} summarises the ELISA results in J16 and HJ16 cells following various treatments.

### Comparison of basal level concentrations of Ft subunits in J16 and HJ16 cells {#s0130}

As can be seen in [Fig. 6](#f0030){ref-type="fig"}, the "basal" levels of FtH in the J16 cell line (381±54 ng/mg) were found to be more than 7-fold higher than those in the HJ16 cell line (52±2 ng/mg). The lower FtH levels in HJ16 cells might be part of the adaptive response developed during gradual adaptation of these cells to H~2~O~2~. However, when FtL levels were measured, J16 and HJ16 cells had similar basal levels of 10.2±3 ng/mg and 9.2±1 ng/mg in J16 and HJ16 cells, respectively.

### *Effect of H*~*2*~*O*~*2*~*on Ft subunit levels in J16 and HJ16 cells* {#s0135}

The FtH ELISA carried out immediately (i.e., 0 h in [Fig. 6](#f0030){ref-type="fig"}A) after the treatment of cells with 0.5 mM H~2~O~2~ showed already significant decreases in the FtH levels in J16 cells (i.e., to 70% of the control value). The FtH levels continued to gradually decrease to 34% of the control value until 6 h after H~2~O~2~ treatment and then remained low and unchanged up to 24 h after H~2~O~2~ treatment (see [Figs. 6](#f0030){ref-type="fig"}C and [7](#f0035){ref-type="fig"}). In contrast, in HJ16 cells, the FtH levels did not significantly change over the period of 0 to 24 h after H~2~O~2~ treatment (see [Figs. 6](#f0030){ref-type="fig"}B, D, and [7](#f0035){ref-type="fig"}). The time course study also revealed no change in the FtL level in J16 cells up to 24 h after H~2~O~2~ treatment ([Fig. 6](#f0030){ref-type="fig"}A and C and data not shown). In contrast, in HJ16 cells there was a slight increase in FtL level following H~2~O~2~ treatment (i.e., up to 2.8-fold of control value) which was sustained up to 24 h after H~2~O~2~ treatment ([Fig. 6](#f0030){ref-type="fig"}B and D and data not shown).

### *Effect of DFO +/-- H*~*2*~*O*~*2*~*on Ft subunit levels in J16 and HJ16 cells* {#s0140}

The treatment of cells with 100 µM DFO for 18 h reduced the FtH levels in the J16 cell line to 8% of the control value (see [Fig. 6](#f0030){ref-type="fig"}A). The low level of FtH in J16 cells was sustained even when cells were incubated in CM without DFO for an additional 24 h (see [Fig. 6](#f0030){ref-type="fig"}C). In HJ16 cells, DFO treatment also decreased the FtH levels, although to a lesser extent than in J16 cells (i.e., to 38% of the control value; see [Fig. 6](#f0030){ref-type="fig"}B). The FtH levels of HJ16 cells further decreased to 15% of the control value following 24 h incubation in CM without DFO (see [Fig. 6](#f0030){ref-type="fig"}D). The FtL levels on the other hand were only significantly decreased in DFO-treated J16 cells but not in DFO-treated HJ16 cells (see [Fig. 6](#f0030){ref-type="fig"}A--D). The H~2~O~2~ treatment of cells that were pretreated with DFO did not further modulate the levels of FtH and FtL subunits in either cell line when compared to cells treated with DFO alone (see [Fig. 6](#f0030){ref-type="fig"}A--D).

Evaluation of the intracellular antioxidant defence {#s0145}
---------------------------------------------------

### Evaluation of catalase and GPx activities {#s0150}

It is well established that most of the H~2~O~2~ in cells is eliminated by the intracellular antioxidant enzymes, catalase and GPx. To investigate whether higher resistance of HJ16 cells to H~2~O~2~ was related to their higher catalase activity, the basal level of catalase activity was determined spectrophotometrically by following the rate of H~2~O~2~ consumption in both cell lines as detailed under Materials and methods. The results (see [Table 2](#t0010){ref-type="table"}) showed no significant difference in the level of catalase activity between parental and H~2~O~2~-resistant cells, suggesting that there is no correlation between this enzymatic activity and the resistance of cells to H~2~O~2~. In addition to catalase, the GPx activity was also measured in both parental and H~2~O~2~-resistant cells. The results (see [Table 2](#t0010){ref-type="table"}) showed that the GPx activity was significantly different between the parental and the H~2~O~2~-resistant cells. Indeed the GPx activity in H~2~O~2~-resistant cells (124.69±24.59) was 1.5-fold higher compared to the parental cells (88.25±14.67). Taken together these data indicate that higher GPx activity in H~2~O~2~-resistant cells might play a role in the resistance of HJ16 cells to H~2~O~2~.

### Evaluation of the intracellular glutathione levels {#s0155}

To determine whether the total intracellular levels of glutathione play a role in increased resistance of HJ16 cell line to H~2~O~2~, the basal glutathione levels of both parental (J16) and H~2~O~2~-resistant (HJ16) cell lines were monitored using the methodology established by Tietze (see Materials and methods). The results revealed that HJ16 cells possess significantly higher levels (3.4-fold) of intracellular glutathione than J16 cells (see [Table 2](#t0010){ref-type="table"}). We also evaluated the levels of intracellular glutathione following H~2~O~2~ treatment in both J16 and H16 cell lines. The results ([Fig. 8](#f0040){ref-type="fig"}A and B) showed that H~2~O~2~ concentrations higher than 0.1 mM deplete the total intracellular glutathione content of the J16 cell line almost entirely. However in HJ16 cells, H~2~O~2~ treatment only decreased the glutathione content by half.

To ascertain whether the lower depletion of the total intracellular glutathione levels of HJ16 cells plays a role in the higher resistance of these cells to H~2~O~2~, we decided to deplete the intracellular glutathione content of both cell lines with BSO and then measure the viability of cells after H~2~O~2~ treatment. BSO is known to be a relatively nontoxic compound whose effect is apparently restricted to the inhibition of γ-glutamylcysteine synthetase [@bib53]. Indeed the evaluation of the toxicity of BSO toward the cells with the MTT assay in the present study also confirmed its lack of toxicity up to the highest concentration analysed (250 µM for 18 h, data not shown).

The evaluation of the intracellular glutathione level of cells that were exposed to increasing concentrations of BSO (i.e., 2, 5, 15, 25, 50, and 250 µM) for 18 h further revealed that a BSO dose of 25 µM was sufficient to deplete entirely the total intracellular glutathione content of both J16 and HJ16 cell lines (data not shown). Using this concentration of BSO, we investigated the susceptibility of both cell lines to H~2~O~2~ treatment following the depletion of their glutathione content. For this purpose, J16 and HJ16 cell lines were first incubated for 18 h with 25 µM BSO and then treated with H~2~O~2~ concentrations up to 1 mM, since the H~2~O~2~ dose of 3 mM was lethal to the J16 cell line. The flow cytometry performed 24 h following H~2~O~2~ treatment ([Fig. 8](#f0040){ref-type="fig"}C and D) revealed that in both cell lines, the susceptibility of cells to H~2~O~2~-mediated necrotic cell death substantially increased in BSO-treated cells.

### Evaluation of FtMt levels in the J16 and HJ16 cell line {#s0160}

We also investigated whether adaptation of J16 cells to high concentrations of H~2~O~2~ modulates the level of FtMt in the H~2~O~2~-adapted HJ16 cells. For this purpose, we first measured the basal level concentrations of FtMt in both cell lines. The results revealed that in HJ16 cells, the basal FtMt levels were 3-fold higher than in J16 cell lines (i.e.,1.52±0.3 ng/mg in HJ16 cells and 0.53±0.2 ng/mg in J16 cells). The higher FtMt levels in HJ16 cells might be part of the adaptive response of cells to high doses of H~2~O~2~. We also measured the FtMt levels 24 h following treatment of both cell lines with 0.5 mM H~2~O~2~. The results showed that while the change in FtMt levels in H~2~O~2~-treated J16 cells was negligible~,~ in the HJ16 cell line, FtMt levels were increased up to 4-fold after H~2~O~2~ treatment (i.e., 5.9±0.6 ng/mg in HJ16 cells and 0.48±0.4 ng/mg in J16 cells). The H~2~O~2~-mediated increase in FtMt may be in part responsible for higher resistance of HJ16 cells to H~2~O~2~. Furthermore the lower cytosolic labile iron release in H~2~O~2~-treated HJ16 cells compared to J16 cells may also be related in part to both higher FtMt basal and higher H~2~O~2~-induced levels of FtMt in H~2~O~2~-adapted HJ16 cells.

Discussion {#s0165}
==========

The central observation to emerge from the present study is that the chronic adaptation of the Jurkat T J16 cells to high concentrations of H~2~O~2~ provokes a series of adaptive responses both at the basal and the "oxidant-induced" levels, allowing cells to withstand high doses of H~2~O~2~ that would otherwise be lethal to the cells. These adaptive responses include both alterations in antioxidant defence and iron homeostasis as summarised in [Fig. 9](#f0045){ref-type="fig"}A. The possible mechanisms underlying the resistance of HJ16 cells to H~2~O~2~ are discussed below.

Role of antioxidant defence {#s0170}
---------------------------

The higher GPx activity and the higher basal level concentrations of glutathione appear to act as the first line of defence against the H~2~O~2~-mediated ROS formation and oxidative damage in HJ16 cells. However catalase activity is quite similar between the parental J16 and the H~2~O~2~-adapted HJ16 cells, suggesting that catalase has a minor role in detoxifying H~2~O~2~. In a study by Spitz et al. (1988, [@bib54]), gradual adaptation of Chinese hamster fibroblasts to an H~2~O~2~ concentration of 800 µM increased the catalase activity of a H~2~O~2~-tolerant cell line when compared to the H~2~O~2~-sensitive cell line. These results are in contrast to our study. Differences between the cell line used (i.e., fibroblasts versus T cells), the species, i.e., hamster versus human, and the differential antioxidant defense mechanisms may explain this discrepancy. Furthermore the GSH/GPx-mediated detoxifying system for H~2~O~2~ might be lower in the hamster fibroblast cell line used, compared to our system. The latter parameter has not been investigated in the Spitz et al.'s study [@bib54]. One explanation for the relative importance of GPx and not of catalase in detoxifying H~2~O~2~ in HJ16 cells relates to the intracellular location of these enzymes. Catalase enzyme is located in peroxisomes and its access to cytosolic H~2~O~2~ is limited. However GPx, unlike catalase, is mainly present in the cytosol and requires reduced glutathione to complete the catalytic cycle. So it is likely that HJ16 cells have adopted the more convenient cytosolic GPx/reduced glutathione cycle for efficient removal of H~2~O~2~ because this is more accessible than the compartmentalised catalase.

The higher constitutive antioxidant defence mechanism involving glutathione appears to contribute to higher resistance of HJ16 cells to H~2~O~2~-mediated oxidative damage and necrotic cell death. The depletion of intracellular glutathione content with BSO renders the HJ16 cells highly vulnerable to H~2~O~2~-mediated oxidative damage and cell death. The reduced response of HJ16 cells to oxidant-induced glutathione depletion also appears to be an important factor contributing to the higher resistance of HJ16 cells to H~2~O~2~-mediated oxidative damage and cell death. While H~2~O~2~ concentrations higher than 0.1 mM provoked a concentration-dependent decrease in intracellular glutathione levels in J16 cells, in HJ16 cells the same concentrations decreased the intracellular glutathione content to only half of the original value. However despite the partial depletion of glutathione in H~2~O~2~-treated HJ16 cells, in quantitative terms the protection afforded by glutathione against H~2~O~2~-induced damage in HJ16 remained very effective since the overall glutathione content of H~2~O~2~-treated HJ16 cells still remained substantially higher than that of H~2~O~2~-treated or untreated J16 cells.

The increase in the basal level concentrations of FtMt that appears to compensate for the adaptive decrease in the basal FtH subunit levels following chronic exposure of J16 cells to H~2~O~2~ provides a second important line of constitutive defence against oxidative damage. FtMt overexpression has been shown to reduce cytosolic Ft level and iron availability by causing an influx of iron from cytosol to mitochondria [@bib40; @bib55]. Furthermore in Hela cells, FtMt overexpression has been shown to protect the mitochondrial functionality and to lower oxidative damage induced by H~2~O~2~ by regulating local iron availability, making these cells more resistant to iron-mediated oxidative damage [@bib37]. Both higher basal and oxidant-induced levels of FtMt are important in buffering excess ROS formation though the regulation of mitochondrial and cytosolic LIP availability on oxidising insult. More specifically in our study, the lower level of oxidant-induced cytosolic labile iron release in HJ16 cells when compared to J16 cells may be in part related to the regulation of cytosolic LIP by higher basal and oxidant-induced levels of FtMt..

The comparison of the intracellular DCFH oxidation level in J16 cells and HJ16 cells treated with H~2~O~2~ also revealed that HJ16 cells exhibit lower DCFH oxidation than J16 cells, consistent with the notion that the antioxidant defense mechanisms in HJ16 are almost certainly higher than in J16 cells (data not shown).

Apart from the parameters studied here, autophagic activation as a cell repair mechanism [@bib56] may also contribute to higher resistance of HJ16 cells to oxidative stress. The differences observed may also be related to the difference in H~2~O~2~ uptake between the two cell lines. Further studies are necessary to gain insight into the involvement of these latter parameters.

Role of cytosolic LIP {#s0175}
---------------------

Previous work from this laboratory with skin cells has demonstrated that both UVA and H~2~O~2~ promote an immediate increase in cytosolic LIP, which in turn potentiates cell death [@bib20; @bib21; @bib24]. To determine to what extent the intracellular LIP plays a role in the resistance of cells to H~2~O~2~, both cell lines were treated with DFO and then the levels of LIP and necrosis were measured following H~2~O~2~ treatment. The results summarised in [Fig. 9](#f0045){ref-type="fig"}B demonstrate that DFO treatment abolishes both the basal and the H~2~O~2~-induced LIP levels and necrotic cell death in both cell lines; consistent with the notion that the chelation of intracellular LIP by DFO protects the cells against H~2~O~2~-induced necrotic cell death. Furthermore in a parallel study, we have observed that iron loading of HJ16 cells with hemin abolishes the resistance of HJ16 cells to H~2~O~2~-induced necrotic death as a result of an increase in both basal and H~2~O~2~-induced levels of LIP (data not shown). These results confirm that cellular damage and the lethal effect of H~2~O~2~ treatment is tightly linked to the intracellular LIP levels. Interestingly human epidermal keratinocytes that are naturally resistant to UVA-induced damage possess lower intracellular LIP levels than the UVA-sensitive dermal fibroblasts. In quantitative terms, keratinocytes also release less cytosolic labile iron after UVA than the UVA-sensitive dermal fibroblasts and this has been correlated with their low propensity to undergo UVA-induced necrotic cell death [@bib21].

Role of cytosolic Ft {#s0180}
--------------------

A striking difference between J16 and HJ16 cells is the remarkably low basal level concentrations of FtH in HJ16 cells when compared to J16 cells. The lower FtH level in HJ16 appears to be part of the adaptive response developed during gradual adaptation of these cells to H~2~O~2~. As for FtL, they had the same basal level in both cell lines. However in the study carried out by Lipinski et al. [@bib57], using mouse lymphoma cell lines with inverse cross-sensitivity to ionizing radiation (IR) and H~2~O~2~, it was found that both the FtH and the FtL levels were higher in the H~2~O~2~-resistant (and IR-sensitive) cells than in the H~2~O~2~-sensitive (and IR-resistant) cells. The latter result differs from our study, presumably due to the difference in cell type (i.e., murine versus human) and the mechanisms underlying the resistance of these cells to both IR and H~2~O~2~. Indeed while in our study the H~2~O~2~ resistance in HJ16 cells was developed following chronic adaptation of the parental J16 cells to high concentrations of H~2~O~2~, in Lipinski's study the H~2~O~2~ resistance was a consequence of the spontaneous conversion of the parental cell line (IR-resistant) to a mutant cell line (IR-sensitive) which was accompanied by an unexpected increase in H~2~O~2~ resistance of the mutated cells [@bib58]. In the latter study, Northern blotting analysis revealed that the level of TfR1 mRNA was also higher in H~2~O~2~-sensitive (and IR-resistant) than the H~2~O~2~-resistant (and IR-sensitive) sensitive cell line. Accordingly the basal level of LIP was also higher in H~2~O~2~-sensitive (and IR-resistant) cells. In contrast, in our study, Western blot analysis revealed no difference in TfR1 protein levels in both cell lines (data not shown) and this is consistent with the similar levels of basal LIP observed in our cell lines. In other words, while both J16 cells and HJ16 cells will manifest similar iron uptake by TfR1, the gradual adaptation of cells to H~2~O~2~ modulates specifically the FtH subunit of Ft. This modulation does not affect the overall labile iron levels in cells consistent with the notion that iron homeostasis in HJ16 cells is still effective in maintaining a low basal level of intracellular LIP.

The adaptive reduction in the basal level concentrations of FtH in HJ16 cells appears to be a way in which cells can lower their overall level of cytosolic Ft that may otherwise act as a pro-oxidant under oxidative stress conditions releasing its iron either reductively or proteolytically on oxidizing insult [@bib19; @bib20; @bib29; @bib34; @bib59]. Studies from this laboratory have already demonstrated a link between lower Ft levels and higher resistance of skin keratinocytes to oxidizing agents such as UVA and H~2~O~2~ when compared to their matched oxidant-sensitive skin fibroblasts [@bib2; @bib8; @bib21]. Within this context, Ft has been shown to act as a pro-oxidant, since its oxidant-mediated proteolytic degradation led to increased levels of potentially harmful LIP contributing to oxidative damage and cell death in skin cells [@bib20; @bib21].

Our results demonstrate that DFO treatment not only fully depletes the intracellular LIP in both cell lines but also substantially decreases the level of Ft in the cells. The DFO treatment also fully protects both cell lines against H~2~O~2~-induced necrotic cell death. The protection afforded by DFO against H~2~O~2~-mediated cell death may be related to its dual action (i) as a suppressor of Ft synthesis that is a potential source of LIP in H~2~O~2~-treated cells and (ii) as a direct chelator of potentially harmful LIP that contributes to oxidative damage and cell death in H~2~O~2~-treated cells.

The lower level of FtH in HJ16 cells may also be due to IRP1-mediated suppression of Ft synthesis as a result of chronic exposure to H~2~O~2~ as observed in studies involving murine cultured cells exposed to H~2~O~2~ [@bib8; @bib29; @bib60]. This assumption is consistent with the observation that in J16 cells, acute exposure of cells to an H~2~O~2~ concentration of 0.5 mM also reduces substantially the level of FtH.

In our study, we found that the overall FtH subunit levels of both cell lines were significantly higher than the FtL subunit levels. Unlike FtH, FtL does not seem to have a major role in iron homeostasis since, for example, subjects with genetic hyperferritinemia-cataract syndrome have nearly 10-fold higher FtL than normal with no obvious abnormalities in iron metabolism [@bib61; @bib62]. Accordingly FtL knockdown did not have a significant impact on intracellular iron availability [@bib63]. Within this context, the H~2~O~2~-mediated increase in FtL expression observed in HJ16 cells may also not be related to iron but rather to its other functions such as stabilising the Ft shell. Since FtH subunit levels are very low in HJ16 cells, H~2~O~2~ exposure may lead to an increase in FtL expression as a compensatory protective mechanism to consolidate the stability of the Ft shell under oxidative stress conditions. Further studies are necessary to understand the functional significance of FtL increase under certain oxidative stress conditions.

*Mechanism underlying H*~*2*~*O*~*2*~*-induced necrotic cell death in J16 cells* {#s0185}
--------------------------------------------------------------------------------

[Fig. 10](#f0050){ref-type="fig"} summarizes potential pathways by which H~2~O~2~ promotes an increase in cytosolic LIP leading to necrotic cell death in J16 cells. Clearly the presence of high levels of redox-active labile iron in lysosomes and mitochondria of J16 cells sensitises these organelles to H~2~O~2~-induced oxidative damage, and consequently exposure of J16 cells to H~2~O~2~ promotes concentration-dependent damage to these organelles. A recent biophysical study looking at the speciation and distribution of iron (i.e., ironome) in intact human Jurkat cells and their isolated mitochondria has also confirmed the presence of high levels of nonheme high-spin Fe^II^ species (a substantial portion of which is LIP) in the mitochondrial organelles [@bib64]. The rapid release of labile iron from these organelles is likely to contribute to the measurable increase in cytosolic LIP which in turn exacerbates the oxidative damage to cell constituents. While the cytosolic LIP is physiologically kept low in cells by storage in Ft, the H~2~O~2~-induced decrease in Ft further contributes to the expansion of cytosolic LIP. The low level of the key iron-storage protein Ft within the critical first hours after H~2~O~2~ treatment is likely to further exacerbate the iron-catalyzed damage in H~2~O~2~-treated J16 cells, since a potentially harmful excess of cytosolic LIP cannot be safely sequestered. Indeed the increase in cytosolic LIP along with highly reactive ROS generated by iron-catalysed Fenton chemistry involving H~2~O~2~ is expected to promote further peroxidative damage in exposed cells notably in plasma membranes resulting in a loss of cell membrane integrity. The latter should predispose the cells to necrotic cell death as a result of the influx of extracellular media to the intracellular environment leading to swelling and rupture of subcellular compartments and cell lysis. Concomitant with destabilisation of the cell membrane, H~2~O~2~ also promotes an immediate depletion of mitochondrial ATP, which is a hallmark of necrotic cell death [@bib21]. The H~2~O~2~-induced mitochondrial ATP depletion is thought to be triggered by several simultaneous events. First the presence of a high level of LIP in mitochondria may initiate the destabilisation of mitochondrial membranes on H~2~O~2~ treatment as a result of iron-induced oxidative damage. Second the H~2~O~2~-induced expansion of cytosolic LIP by lysosomal damage as well as the concomitant decrease in Ft level is likely to exacerbate the iron-catalysed oxidative damage that already occurs in the mitochondrial membrane. Finally the rapid release of lysosomal proteases after H~2~O~2~ treatment might further damage the mitochondrial membrane leading to additional permeabilisation of the mitochondrial organelles. All these events will almost certainly contribute to the observed H~2~O~2~-induced rapid depletion of mitochondrial ATP that leads to the demise of cells in the form of necrosis. Pretreatment of J16 cells with DFO dramatically decreased the levels of lysosomal and plasma membrane damage and necrotic cell death. The lack of an oxidative effect of H~2~O~2~ in the presence of DFO strongly suggests that H~2~O~2~ per se is not particularly toxic but rather must work in concert with labile iron in order to damage cells. The measurement of intracellular ROS level after H~2~O~2~ treatment in J16 cells that were pretreated with the iron chelator SIH also revealed that the level of ROS present in SIH-treated cells is substantially lower than in J16 cells treated with H~2~O~2~ alone (data not shown).

Overall our results demonstrate that the levels of damage and cell death in both cell lines are relatively low and comparable, when cells are exposed to low H~2~O~2~ concentrations of 0.05 and 0.1 mM. J16 cells are not sensitive to low concentrations of H~2~O~2~ (i.e., 0.05 and 0.1 mM), presumably because their antioxidant defence mechanisms are sufficient to counteract the damaging effects of the low H~2~O~2~ concentrations applied. However at high H~2~O~2~ concentrations (i.e., 0.5--3 mM), the antioxidant defence mechanism in the J16 cell line appears to be insufficient to cope with such high acute oxidative insult, resulting in a high percentage of cell death. In contrast in HJ16 cells, the chronic adaptation of cells to high concentrations of H~2~O~2~ has provoked a series of novel and specific adaptive responses that contribute to higher resistance of HJ16 cells to high concentrations of H~2~O~2~ (i.e., 0.5--3 mM). These include increased cellular antioxidant defence in the form of higher glutathione and FtMt levels, higher GPx activity, and lower FtH levels. Further adaptive responses include the significantly reduced cellular response to oxidant-mediated glutathione depletion, FtH modulation, and labile iron release and a significant increase in FtMt levels following H~2~O~2~ treatment.

The findings of this study have direct relevance to understanding the interplay between iron and chronic exposure to ROS, notably H~2~O~2~ in promotion and progression of pathological conditions where there is a substantial local increase in the production of H~2~O~2~ beyond the physiological level produced in the cells. In such pathological conditions the existing antioxidant defence mechanism in cells will be insufficient to counteract the H~2~O~2~-mediated damage. As a result cells will die by apopotosis or necrosis or alternatively will develop novel and specific adaptive antioxidant mechanisms allowing cells to withstand high levels of ROS notably H~2~O~2.~ For example in rheumatoid arthritis (RA), the rheumatoid synovium is relatively hypoxic, and is exposed to chronic cycles of hypoxia and reperfusion. This promotes the generation of substantial ROS, notably H~2~O~2~ within the rheumatoid synovium which has marked effects on many cell types, including enhanced production of proinflammatory cytokines by mononuclear cells. Furthermore several studies indicate that, during an inflammatory response, considerable amounts of ROS, notably H~2~O~2~, are generated that participate in the etiology and/or the progression of the condition. For example, in an inflammatory environment, lymphocytes are exposed repeatedly to high concentrations of H~2~O~2~ produced by macrophages and neutrophils as a result of the inflammatory response. Recent data from this laboratory have also revealed that rheumatoid synovial fibroblasts are highly resistant to oxidative damage caused by high concentrations of H~2~O~2~, presumably as a result of adaptation to chronic exposure to H~2~O~2~ that is produced locally in the inflammatory arthritic synovium (data not shown). Therefore, understanding the mechanism underlying the adaptation of cells to chronic exposure to high concentrations of H~2~O~2~ in this study is directly relevant to pathological conditions such as RA. This study may provide clues for the development of novel therapeutic strategies targeting ROS, iron and iron-related proteins, notably Ft, in chronic inflammatory disorders.
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![(A) An example of the evaluation of flow cytometry analysis 24 h following H~2~O~2~ treatment. Cells were treated with 0, 0.5, and 3 mM H~2~O~2~. The analysis was performed 24 h after H~2~O~2~ treatment following dual Annexin-V/PI staining. Live cells are situated in the lower left quadrant (LL), apoptotic cells are situated in the lower right quadrant (LR), and primary and secondary necrotic cells are situated in the upper left (UL) and upper right (UR) quadrants, respectively. (B) The effect of H~2~O~2~ on the percentage of apoptosis and necrosis in J16 and HJ16 cell lines. Cells were treated with H~2~O~2~ at final concentrations of 0, 0.5, 1, and 3 mM. The percentages of live, necrotic, and apoptotic cells were scored 24 h following the H~2~O~2~ treatment by flow cytometry. The results are expressed as mean ± SD (*n*=3). + *P* \< 0.05, significant difference between treated and corresponding controls (Live cells). \* *P* \< 0.05, significantly different from HJ16 cell line (Live cells).](gr1){#f0005}

![Effect of H~2~O~2~ and DFO on the intracellular level of ATP in J16 and HJ16 cells. Cells were first treated or not with 100 µM DFO for 18 h at 37 °C. Cells were then incubated for 45 min in PNG prior to treatment with H~2~O~2~ at final concentrations of 0, 0.05, 0.1, 0.5, and 1 mM. The intracellular level of ATP was measured 4 and 24 h following H~2~O~2~ treatment with the Apoglow kit. Data are expressed as mean ± SD (*n*=3--5). A and B are plotted as fold change in ATP when compared to the corresponding untreated control. C--F are plotted as percentage change in ATP when compared to the corresponding untreated control. \**P* \< 0.05, significant difference between J16 and HJ16 cells at 4 or 24 h time points. + *P* \< 0.05, significant difference between DFO-treated and the corresponding untreated cell lines at 4 or 24 h time points. (A) 4h, (B) 24h, (C) J16 4h, (D) HJ16 4h, (E) J16 24h and (F) HJ16 24h.](gr2){#f0010}

![Evaluation of H~2~O~2~-mediated damage to lysosomes in J16 and HJ16 cells. Cells were first treated (or not) with 100 µM DFO for 18 h and then exposed to H~2~O~2~ at final concentrations of 0, 0.1, 0.5, 1, and 3 mM. The Lysosensor green (A), cathepsin B immunostaining (B), and NR assays (C--E) were performed 24 h following H~2~O~2~ treatment as detailed under Materials and methods. For A and B, the photographs are representative of three independent experiments. In B--D, results are expressed as mean ± SD (*n*=3--5). \**P* \< 0.05, significantly different from the corresponding control. + *P* \< 0.05, significantly different from the corresponding J16 cells.](gr3){#f0015}

![LIP measurements in J16 and HJ16 cells with or without H~2~O~2~ treatments. LIP determination was performed immediately after H~2~O~2~ treatment. The results are expressed as mean ± SD (*n*=3--8). \**P* \< 0.05, significantly different from the corresponding HJ16 cells. + *P* \< 0.05, significantly different from the corresponding untreated control.](gr4){#f0020}

![Effect of H~2~O~2~ ± DFO treatment on the level of necrotic cell death in J16 and HJ16 cells. Both cell lines were treated with 100 μM DFO for 18 h before H~2~O~2~ treatment. Flow cytometry assay was performed 24 h following H~2~O~2~ treatment. The results are expressed mean ± SD (*n*=3). \**P \< 0.05*, significantly different from cells treated with H~2~O~2~ alone.](gr5){#f0025}

![FtH and FtL measurements in J16 and HJ16 cell lines ± H~2~O~2~ and/or DFO. FtH and FtL measurements were performed by ELISA. For DFO treatment, cells were first treated for 18 h with 100 µM DFO and then the ELISA was performed either immediately (0 h) or following 24 h incubation in conditioned media without DFO. For H~2~O~2~ treatments, cells pretreated or not with DFO were analyzed by ELISA either immediately, i.e., H~2~O~2~ (0 h) or 24 h after H~2~O~2~ treatment, i.e., H~2~O~2~ (24 h). The results are expressed as mean ± SD (*n*=3). \**P \< 0.05*, significantly different from the corresponding untreated control.](gr6){#f0030}

![Modulation of FtH level following treatment of J16 and HJ16 cell lines with 0.5 mM H~2~O~2.~ Whole cellular extracts from J16 and HJ16 cell lines were first prepared 0, 2, 4, 6, 8, 18, and 24 h after H~2~O~2~ treatment with an intermediate dose of 0.5 mM and then analyzed by ELISA. Data are expressed as mean ± SD (*n*=3). \**P* \< 0.05, significantly different from the corresponding control. + *P* \< 0.05, significantly different from the corresponding value of the other cell line.](gr7){#f0035}

![The effect of H~2~O~2~ (+/-- BSO) on modulation of intracellular glutathione level and its impact on cell survival. A and B are the determination of total intracellular glutathione level by Tietze's method 24 h after treatment of J16 (A) and HJ16 (B) cells with various concentrations of H~2~O~2~. The results are expressed as mean ± SD (*n*=3). \**P* \< 0.05, significantly different from the corresponding untreated control. C and D represent the percentage survival of J16 and HJ16 cells as determined by flow cytometry 24 h following H~2~O~2~ treatment of cells pretreated (or not) with 25 µM BSO for 18 h. The results are expressed as mean ± SD (*n*=3). \**P* \< 0.05, significantly different from the corresponding control of the same treatment. + *P* \< 0.05, significantly different from BSO-treated cells.](gr8){#f0040}

![Schematic diagram illustrating the main differences observed in the present study between J16 and HJ16 cells treated or not with H~2~O~2~ (A) and/or DFO (B). Abbreviations: GSH, glutathione; GPx, glutathione peroxidase; FtMt, mitochondrial ferritin; FtH, ferritin heavy chain; LIP, labile iron pool. In A after H~2~O~2~ treatment, the upward arrows in the boxes indicate increase and downward arrows indicate decrease.](gr9){#f0045}

![Schematic diagram illustrating the potential pathways involved in H~2~O~2~-induced cytosolic labile iron release and necrotic cell death in J16 cells. Exposure of J16 cells to H~2~O~2~ catalyses the formation of ROS (orange colour) that promotes oxidative damage in lysosomal (1) and mitochondrial (2) membranes. Damage to lysosomal membrane (1) leads to release of lysosomal proteases (1a) that may contribute to Ft degradation (1a.1) and release its iron in the labile form (LI) (hatched arrow). Although the decrease in Ft level in J16 cells may be due to H~2~O~2~-mediated suppression of Ft synthesis (3). In this scenario Ft iron does not contribute to the increase in cytosolic LIP. The release of lysosomal proteases (1a) may also contribute to mitochondrial membrane damage (1a.2). The H~2~O~2~-mediated damage to mitochondrial membrane (2) leads to interruption of electron chain transport in mitochondrial membrane causing the generation of ROS, loss of the electrochemical gradient across the inner membrane, and ATP depletion (2b). The release of potentially harmful labile iron (LI) in cytosol via routes 1 and 2, along with the preexisting pool of cytosolic LIP, contributes to a massive increase in cytosolic LIP that catalyses the formation of more harmful ROS (in red) that is thought to further exacerbate the peroxidative damage in the lysosomal (1b), mitochondrial (2a), and plasma (4) membranes leading to the loss of organelles' and plasma membrane's integrity. The loss of plasma membrane integrity (4b) together with the mitochondrial ATP depletion (2b) results in necrotic cell death.](gr10){#f0050}

###### 

Evaluation of cytosolic LIP in J16 and HJ16 cells.

  Condition_Cell line                LIP (µM)
  ---------------------------------- -----------------------------------------------------------------------------------
  Control (basal)\_J16               3.08±0.59
  Control (basal)\_HJ16              3.34±0.87
                                     9.86±0.15[\*](#tbl1fn1){ref-type="table-fn"}
  0\. 5 mM H~2~O~2~\_HJ16            5.27±1.12[\*](#tbl1fn1){ref-type="table-fn"}^,^[†](#tbl1fn2){ref-type="table-fn"}
  100 µM DFO_J16                     0[\*](#tbl1fn1){ref-type="table-fn"}
  100 µM DFO_HJ16                    0[\*](#tbl1fn1){ref-type="table-fn"}
  100 µM DFO+ 0.5 mM H~2~O~2~\_J16   0[\*](#tbl1fn1){ref-type="table-fn"}
  100 µM DFO+0.5 mM                  0[\*](#tbl1fn1){ref-type="table-fn"}

LIP measurements were performed with CA assay. Control samples provide the basal cytosolic LIP levels in the absence of treatments. The LIP measurements of H~2~O~2~-treated cells were carried out immediately after 0.5 mM H~2~O~2~ treatment of cells pretreated or not with 100 µM DFO for 18 h. The results are expressed as mean ± SD (*n*=3--8).

*P* \< 0.05, significant difference between the treated and the corresponding control.

*P* \< 0.05, significantly different from the corresponding J16 cell line.

###### 

Evaluation of intracellular glutathione level and catalase and GPx activities in J16 and HJ16 cells

  Cell line   Catalase activity (*n*=4) (Unit / mg protein)   GPx activity (*n*=5) (Unit / mg protein)          Glutathione level (*n*=4) (µM glutathione / mg protein)
  ----------- ----------------------------------------------- ------------------------------------------------- ---------------------------------------------------------
  J16         0.35±0.12                                       88.25±14.6                                        0.47±0.07
  HJ16        0.29±0.11                                       124.69±24.59[\*](#tbl2fn1){ref-type="table-fn"}   1.61±0.67[\*](#tbl2fn1){ref-type="table-fn"}

The results are expressed as mean ± SD.

*P* \< 0.05, significantly different from value of J16 cell line.

[^1]: These authors contributed equally to this work.
